8 research outputs found
Recommended from our members
The effect of ApoE4 on neurovascular coupling in the visual cortex
Neurovascular coupling (NVC) is the process whereby the brain increases local blood supply in response to neuronal activity, providing neurons with energy. Disruptions to NVC have been implicated in Alzheimer's disease (AD), so a better understanding of how NVC goes wrong, and when, is imperative for better understanding the disease and assisting in the identification of therapeutic targets. The main genetic risk factor for developing AD, expression of Apolipoprotein ε4 (APOE4), is associated with vascular deficits, including pericyte damage and impaired cerebral blood ow. I tested whether expression of APOE4 affected NVC, by studying neuronal activity and vascular responses in visual cortex.
To investigate this, mice with humanised APOE4 or APOE3 were crossed with mice expressing a genetically-encoded calcium indicator or with labelled pericytes. Mice were implanted with a cranial window over visual cortex and neuronal and vascular activity was recorded using two-photon microscopy. Baseline and stimulus evoked measurements were taken to determine the effect of ApoE4 on basal energy balance and on the ability of the brain to deliver adequate energy to neurons.
Results suggest that there were some baseline alterations in APOE4 mice that may result in a lower energy supply. Compounding this, I found there to be a mismatch in energy supply and demand during sensory stimulation, where neuronal demand was greater, but blood supply was less reliable in APOE4 mice.
Together these data suggest that there could be an energy deficit in APOE4 carriers. In vivo studies investigating the role of ApoE4 in NVC are few and the study of individual vessels and neurons across different age points, as done in this body of work, is a novel and unique approach. By better understanding how ApoE4 modulates neurovascular function, we can better understand its role in AD pathology and possibly identify therapeutic targets in the future
Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages
Clinico-pathological correlation studies show that some otherwise healthy elderly individuals who never developed cognitive impairment harbor a burden of Alzheimer’s disease lesions (plaques and tangles) that would be expected to result in dementia. In the absence of comorbidities explaining such discrepancies, there is a need to identify other brain changes that meaningfully contribute to the cognitive status of an individual in the face of such burdens of plaques and tangles. Glial inflammatory responses, a universal phenomenon in symptomatic AD, show robust association with degree of cognitive impairment, but their significance in early tau pathology stages and contribution to the trajectory of cognitive decline at an individual level remain widely unexplored. We studied 55 brains from individuals at intermediate stages of tau tangle pathology (Braak III-IV) with diverging antemortem cognition (demented vs. non-demented, here termed `resilient’), and age-matched cognitively normal controls (Braak 0-II). We conducted quantitative assessments of amyloid and tau lesions, cellular vulnerability markers, and glial phenotypes in temporal pole (Braak III-IV region) and visual cortex (Braak V-VI region) using artificial-intelligence based semiautomated quantifications. We found distinct glial responses with increased proinflammatory and decreased homeostatic markers, both in regions with tau tangles (temporal pole) and without overt tau deposits (visual cortex) in demented but not in resilient. These changes were significantly associated with markers of cortical cell damage. Similar phenotypic glial changes were detected in the white matter of demented but not resilient and were associated with higher burden of overlying cortical cellular damage in regions with and without tangles. Our data suggest that changes in glial phenotypes in cortical and subcortical regions represent an early phenomenon that precedes overt tau deposition and likely contributes to cell damage and loss of brain function predicting the cognitive status of individuals at intermediate stages of tau aggregate burden (Braak III-IV)
Gradual not sudden change: multiple sites of functional transition across the microvascular bed
In understanding the role of the neurovascular unit as both a biomarker and target for disease interventions, it is vital to appreciate how the function of different components of this unit change along the vascular tree. The cells of the neurovascular unit together perform an array of vital functions, protecting the brain from circulating toxins and infection, while providing nutrients and clearing away waste products. To do so, the brain’s microvasculature dilates to direct energy substrates to active neurons, regulates access to circulating immune cells, and promotes angiogenesis in response to decreased blood supply, as well as pulsating to help clear waste products and maintain the oxygen supply. Different parts of the cerebrovascular tree contribute differently to various aspects of these functions, and previously, it has been assumed that there are discrete types of vessel along the vascular network that mediate different functions. Another option, however, is that the multiple transitions in function that occur across the vascular network do so at many locations, such that vascular function changes gradually, rather than in sharp steps between clearly distinct vessel types. Here, by reference to new data as well as by reviewing historical and recent literature, we argue that this latter scenario is likely the case and that vascular function gradually changes across the network without clear transition points between arteriole, precapillary arteriole and capillary. This is because classically localized functions are in fact performed by wide swathes of the vasculature, and different functional markers start and stop being expressed at different points along the vascular tree. Furthermore, vascular branch points show alterations in their mural cell morphology that suggest functional specializations irrespective of their position within the network. Together this work emphasizes the need for studies to consider where transitions of different functions occur, and the importance of defining these locations, in order to better understand the vascular network and how to target it to treat disease
Recommended from our members
A multi-hit hypothesis for an APOE4-dependent pathophysiological state
The APOE gene encoding the Apolipoprotein E protein is the single most significant genetic risk factor for late-onset Alzheimer's disease. The APOE4 genotype confers a significantly increased risk relative to the other two common genotypes APOE3 and APOE2. Intriguingly, APOE4 has been associated with neuropathological and cognitive deficits in the absence of Alzheimer's disease-related amyloid or tau pathology. Here, we review the extensive literature surrounding the impact of APOE genotype on central nervous system dysfunction, focussing on preclinical model systems and comparison of APOE3 and APOE4, given the low global prevalence of APOE2. A multi-hit hypothesis is proposed to explain how APOE4 shifts cerebral physiology towards pathophysiology through interconnected hits. These hits include the following: neurodegeneration, neurovascular dysfunction, neuroinflammation, oxidative stress, endosomal trafficking impairments, lipid and cellular metabolism disruption, impaired calcium homeostasis and altered transcriptional regulation. The hits, individually and in combination, leave the APOE4 brain in a vulnerable state where further cumulative insults will exacerbate degeneration and lead to cognitive deficits in the absence of Alzheimer's disease pathology and also a state in which such pathology may more easily take hold. We conclude that current evidence supports an APOE4 multi-hit hypothesis, which contributes to an APOE4 pathophysiological state. We highlight key areas where further study is required to elucidate the complex interplay between these individual mechanisms and downstream consequences, helping to frame the current landscape of existing APOE-centric literature
First, tau causes NO problem
Pathological tau disrupts the association between nitric oxide (NO) synthase and PSD95, impairing NO signaling and neurovascular coupling before causing neurodegeneration. Stopping production of pathological tau rescues NO signaling, neurovascular coupling and neuronal function, but doesn’t remove tangles, suggesting that (like amyloid-β) soluble tau is an important driver of early neurovascular dysfunction and subsequent neuronal damage
Recommended from our members
Supporting Data for Gradual Not Sudden Change: Multiple Sites of Functional Transition Across the Microvascular Bed
The data provided was used to generate the figures in Shaw et al (2022); Gradual Not Sudden Change: Multiple Sites of Functional Transition Across the Microvascular Bed, Frontiers in Aging Neuroscience. Full details of how the data was generated and processed is provided in that paper. The ReadMe file attached to this record gives details on the data including measurements and column headings.A single Excel spreadsheet containing all the data points used for
graphs in Figures 4-9 and Supplementary Figures 3-6 as individual work
sheets (uploaded as .xlsx), and individual .csv files containing all the
data points used for graphs in Figures 4-9 and Supplementary Figures
2-6 (for non-proprietary format). Abstract In understanding the role of the neurovascular unit as both a biomarker
and target for disease interventions, it is vital to appreciate how the
function of different components of this unit change along the vascular
tree. The cells of the neurovascular unit together perform an array of
vital functions, protecting the brain from circulating toxins and
infection, while providing nutrients and clearing away waste products.
To do so, the brain’s microvasculature dilates to direct energy
substrates to active neurons, regulates access to circulating immune
cells, and promotes angiogenesis in response to decreased blood supply,
as well as pulsating to help clear waste products and maintain the
oxygen supply. Different parts of the cerebrovascular tree contribute
differently to various aspects of these functions, and previously, it
has been assumed that there are discrete types of vessel along the
vascular network that mediate different functions. Another option,
however, is that the multiple transitions in function that occur across
the vascular network do so at many locations, such that vascular
function changes gradually, rather than in sharp steps between clearly
distinct vessel types. Here, by reference to new data as well as by
reviewing historical and recent literature, we argue that this latter
scenario is likely the case and that vascular function gradually changes
across the network without clear transition points between arteriole,
precapillary arteriole and capillary. This is because classically
localised functions are in fact performed by wide swathes of the
vasculature, and different functional markers start and stop being
expressed at different points along the vascular tree. Furthermore,
vascular branch points show alterations in their mural cell morphology
that suggest functional specialisations irrespective of their position
within the network. Together this work emphasises the need for studies
to consider where transitions of different functions occur, and the
importance of defining these locations, in order to better understand
the vascular network and how to target it to treat disease.
<br
Recommended from our members
APOE4 expression confers a mild, persistent reduction in neurovascular function in the visual cortex and hippocampus of awake mice
Vascular factors are known to be early and important players in Alzheimer’s disease (AD) development, however the role of the ε4 allele of the Apolipoprotein (APOE) gene (a risk factor for developing AD) remains unclear. APOE4 genotype is associated with early and severe neocortical vascular deficits in anaesthetised mice, but in humans, vascular and cognitive dysfunction are focused on the hippocampal formation and appear later. How APOE4 might interact with the vasculature to confer AD risk during the preclinical phase represents a gap in existing knowledge. To avoid potential confounds of anaesthesia and to explore regions most relevant for human disease, we studied the visual cortex and hippocampus of awake APOE3 and APOE4-TR mice using 2-photon microscopy of neurons and blood vessels. We found mild vascular deficits: vascular density and functional hyperaemia were unaffected in APOE4 mice, and neuronal or vascular function did not decrease up to late middle-age. Instead, vascular responsiveness was lower, arteriole vasomotion was reduced and neuronal calcium signals during visual stimulation were increased. This suggests that, alone, APOE4 expression is not catastrophic but stably alters neurovascular physiology. We suggest this state makes APOE4 carriers more sensitive to subsequent insults such as injury or beta amyloid accumulation.</p